📣 VC round data is live. Check it out!

Globus Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Globus Medical and similar public comparables like Insulet, Zydus Lifesciences, Align Technology, Fisher & Paykel and more.

Globus Medical Overview

About Globus Medical

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.


Founded

2003

HQ

United States

Employees

6.0K

Financials (LTM)

Revenue: $3B
EBITDA: $977M

EV

$10B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Globus Medical Financials

Globus Medical reported last 12-month revenue of $3B and EBITDA of $977M.

In the same LTM period, Globus Medical generated $2B in gross profit, $977M in EBITDA, and $588M in net income.

Revenue (LTM)


Globus Medical P&L

In the most recent fiscal year, Globus Medical reported revenue of $3B and EBITDA of $920M.

Globus Medical is profitable as of last fiscal year, with gross margin of 67%, EBITDA margin of 31%, and net margin of 19%.

See analyst estimates for Globus Medical
LTMLast FY202320242025202620272028
Revenue$3B$3B$2B$3B$3B
Gross Profit$2B$2B$1B$1B$2B
Gross Margin69%67%65%59%67%
EBITDA$977M$920M$347M$474M$814M
EBITDA Margin32%31%22%19%28%
EBIT Margin25%24%13%9%18%
Net Profit$588M$546M$123M$103M$538M
Net Margin19%19%8%4%18%

Financial data powered by Morningstar, Inc.

Globus Medical Stock Performance

Globus Medical has current market cap of $11B, and enterprise value of $10B.

Market Cap Evolution


Globus Medical's stock price is $79.93.

Globus Medical share price decreased by 11.4% in the last 30 days, and increased by 35.1% in the last year.

Globus Medical has an EPS (earnings per share) of $4.02.

See more trading valuation data for Globus Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$10B$11B1.3%-11.4%-28.2%35.1%$4.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Globus Medical Valuation Multiples

Globus Medical trades at 3.4x EV/Revenue multiple, and 10.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Globus Medical

EV / Revenue (LTM)


Globus Medical Financial Valuation Multiples

As of May 20, 2026, Globus Medical has market cap of $11B and EV of $10B.

Globus Medical has a P/E ratio of 18.5x.

LTMLast FY202320242025202620272028
EV/Revenue3.4x3.5x6.6x4.1x3.5x
EV/EBITDA10.6x11.2x29.8x21.8x12.7x
EV/EBIT13.6x14.6x51.2x47.0x19.2x
EV/Gross Profit5.0x5.2x10.1x7.0x5.2x
P/E18.5x19.9x88.3x105.4x20.2x
EV/FCF38.3x17.8x62.6x25.5x17.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Globus Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Globus Medical Margins & Growth Rates

Globus Medical grew revenue by 9% and EBITDA by 16% in the last fiscal year.

In the most recent fiscal year, Globus Medical reported gross margin of 67%, EBITDA margin of 31%, and net margin of 19%.

See estimated margins and future growth rates for Globus Medical

Globus Medical Margins

Last FY202420252026202720282029
Gross Margin67%59%67%70%
EBITDA Margin31%19%28%33%
EBIT Margin24%9%18%26%
Net Margin19%4%18%20%
FCF Margin20%16%20%12%

Globus Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth9%61%17%9%
Gross Profit Growth13%45%34%13%
EBITDA Growth16%37%72%31%
EBIT Growth19%9%145%56%
Net Profit Growth20%(16%)422%22%
FCF Growth(33%)145%43%(33%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Globus Medical Operational KPIs

Globus Medical's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.

Globus Medical's Rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Globus Medical's Rule of X is 56% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Globus Medical
LTMLast FY202320242025202620272028
Rule of 4040%42%
Bessemer Rule of X52%56%
Revenue per Employee$0.5M
Opex per Employee$0.2M
R&D Expenses to Revenue5%5%8%6%5%
Opex to Revenue49%52%50%49%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Globus Medical Competitors

Globus Medical competitors include Insulet, Zydus Lifesciences, Align Technology, Fisher & Paykel, Fresenius Medical Care, Cooper Companies, Medpace, Baxter International, Masimo and Smith & Nephew.

Most Globus Medical public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Insulet4.1x3.8x17.5x15.9x
Zydus Lifesciences4.0x4.0x12.7x15.0x
Align Technology2.5x2.5x9.4x9.1x
Fisher & Paykel9.2x8.1x28.7x24.0x
Fresenius Medical Care1.0x1.0x5.3x5.4x
Cooper Companies3.5x3.4x11.2x10.7x
Medpace4.5x4.4x20.4x19.8x
Baxter International1.5x1.5x7.5x7.7x

This data is available for Pro users. Sign up to see all Globus Medical competitors and their valuation data.

Start Free Trial

Globus Medical M&A Activity

Globus Medical has acquired 10 companies to date.

Last acquisition by Globus Medical was on February 6th 2025. Globus Medical acquired Nevro for $250M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Globus Medical

Nevro
NuVasive
Synoste Oy
StelKast
Description
Nevro is a global medical device company headquartered in Redwood City, California, that specializes in neuromodulation for chronic pain management. The firm commercializes the Senza spinal cord stimulation system, distinguished by its HF10 therapy delivering high-frequency waveforms at 10 kHz. FDA-approved for back, leg, and intractable pain, Senza treats conditions without paresthesia. Nevro serves patients through physicians in the United States, Europe, and Australia.
NuVasive is a San Diego-based medical technology company developing products for minimally invasive spine surgery. Its portfolio includes the Pulse platform integrating imaging, neuromonitoring, and implants like CoRoent XL cages and Modulus cervical plates. NuVasive serves spine surgeons globally with solutions for lumbar, cervical, and thoracolumbar procedures. Founded in 1999, the company operates in over 20 countries with manufacturing in the U.S. and Europe.
Synoste Oy is a Finnish medtech company developing implantable devices for limb lengthening and skeletal deformity correction using shape memory alloys. Tampere-based since its founding, the startup targets complications in traditional procedures with patient-friendly, precisely controllable implants that enable faster recovery and lower risks. Its lead product utilizes smart materials for less invasive orthopedic treatments.
StelKast is a medical device manufacturer producing implants and surgical instruments for hip and knee arthroplasty. Collaborating with orthopedic surgeons, the company designs cementless stems, acetabular cups, and revision systems emphasizing bone preservation and primary stability. Based in Europe, StelKast delivers modular platforms compatible with robotic-assisted procedures to orthopedic centers worldwide.
HQ CountryUnited StatesUnited StatesFinlandUnited States
HQ City
San Francisco, CA
San Diego, CA
Espoo
Washington, DC
Deal Date6 Feb 20259 Feb 202330 Jun 20202 Aug 2019
Valuation$250M$3B$24M$24M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Globus Medical acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Globus Medical

When was Globus Medical founded?Globus Medical was founded in 2003.
Where is Globus Medical headquartered?Globus Medical is headquartered in United States.
How many employees does Globus Medical have?As of today, Globus Medical has over 6K employees.
Who is the CEO of Globus Medical?Globus Medical's CEO is Keith W. Pfeil.
Is Globus Medical publicly listed?Yes, Globus Medical is a public company listed on NYSE.
What is the stock symbol of Globus Medical?Globus Medical trades under GMED ticker.
When did Globus Medical go public?Globus Medical went public in 2012.
Who are competitors of Globus Medical?Globus Medical main competitors include Insulet, Zydus Lifesciences, Align Technology, Fisher & Paykel, Fresenius Medical Care, Cooper Companies, Medpace, Baxter International, Masimo, Smith & Nephew.
What is the current market cap of Globus Medical?Globus Medical's current market cap is $11B.
What is the current revenue of Globus Medical?Globus Medical's last 12 months revenue is $3B.
What is the current revenue growth of Globus Medical?Globus Medical revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Globus Medical?Current revenue multiple of Globus Medical is 3.4x.
Is Globus Medical profitable?Yes, Globus Medical is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Globus Medical?Globus Medical's last 12 months EBITDA is $977M.
What is Globus Medical's EBITDA margin?Globus Medical's last 12 months EBITDA margin is 32%.
What is the current EV/EBITDA multiple of Globus Medical?Current EBITDA multiple of Globus Medical is 10.6x.
What is the current FCF of Globus Medical?Globus Medical's last 12 months FCF is $270M.
What is Globus Medical's FCF margin?Globus Medical's last 12 months FCF margin is 9%.
What is the current EV/FCF multiple of Globus Medical?Current FCF multiple of Globus Medical is 38.3x.
How many companies Globus Medical has acquired to date?As of May 2026, Globus Medical has acquired 10 companies.
What was the largest acquisition by Globus Medical?$3B acquisition of NuVasive on 9th February 2023 was the largest M&A Globus Medical has done to date.
What companies Globus Medical acquired?Globus Medical acquired NuVasive, Nevro, Alphatec Spine (international distribution unit), Branch Medical Group, Transplant Technologies of Texas, KB Medical, StelKast, Synoste Oy, Surgimap, and Excelsius Surgical.
In how many companies Globus Medical has invested to date?Globus Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Globus Medical

Lists including Globus Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial